Highlights
NASDAQ: NKTR       Nektar Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
21.27   -0.52 (2.39%)  21.01 - 22.02  1,649,100

Overview

 
Avg Volume (4 weeks):2,770,415
4 Weeks Range:17.555 - 23.32
4 Weeks Price Volatility (%):
64.44%
52 Weeks Range:15.635 - 47.11
52 Weeks Price Volatility (%):
17.90%
Average Price Target: 17.00
Price Target Upside/Downside: -4.27

Headlines



No recent Headlines for this stock.


Business Background

Nektar Therapeutics Inc is a biopharmaceutical company that seeks to enable the development of new molecules to treat a number of therapeutic areas including oncology, pain, anti-infectives, and immunology. The company's research and development activities involve small-molecule drugs, peptides, and protein biologic drug candidates. The company decides on a candidate-by-candidate basis how far to advance clinical development and whether to commercialize products on its own, seek a partner, or pursue a combination of these approaches. Nektar's partnershipaims to fund continued clinical development, manage the regulatory filing process, and market and sell drugs in various geographies.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers